optimizing car-t outcomes in dlbcl: possible combination strategies & sequencing of agents
Published 1 year ago • 105 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
2:05
strategies to implement car-t in dlbcl
-
1:04
bispecifics & car-t therapy in dlbcl: sequencing and selecting between these agents
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
2:10
optimizing car-t therapy in lbcl
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
1:55
optimal sequencing of car-t and bispecifics in nhl
-
6:54
the future of car-t therapy in the management of dlbcl
-
3:52
updates on the use of car-t therapy for the treatment of dlbcl in the second-line setting
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
16:43
engineering better car t cells: an interview with cri star yvonne chen, phd
-
5:04
dlbcl and car t cell therapy - kim's lymphoma story
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
0:50
improving car-t cell efficacy: optimizing car constructs and counteracting tumor escape
-
1:07
optimizing car-t therapy: regulating car t-cells in vivo
-
1:29
combining ibrutinib with car-t cells: a promising therapeutic strategy in cll
-
2:42
clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
-
2:33
promising strategies to optimize car-t therapy in all
-
10:41
car t-cell case study: sequencing therapies for patients with high-risk dlbcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:49
car-t cell approaches in cll: current progress & future directions
-
3:21
safety management of car-t cell therapy in dlbcl
-
4:39
intermittent neutrophil recovery associated with improved car-t outcomes in r/r lbcl